657 filings
Page 13 of 33
425
fmkhix
8 Mar 17
Business combination disclosure
12:00am
425
9u7ufx ldq
1 Mar 17
Business combination disclosure
12:00am
8-K
2mosyig399a
28 Feb 17
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
425
qif1lpoj6 fa6
23 Feb 17
Business combination disclosure
12:00am
8-K
thvtj6h
23 Feb 17
OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Year End 2016
12:00am
425
2jegz5kc bk8
21 Feb 17
Business combination disclosure
12:00am
425
gvmmxm9p1
21 Feb 17
Business combination disclosure
12:00am
425
446qe zse6i7wz93ih
6 Jan 17
Business combination disclosure
12:00am
425
tp20z28h550skb
6 Jan 17
Business combination disclosure
12:00am
8-K
hdvqzbb6
6 Jan 17
This presentation contains forward-looking statements, including, but not limited to, statements regarding
12:00am
8-K
79sqyjr4 u7vnum9ps3
5 Jan 17
Announce Definitive Merger Agreement
12:00am
425
s3f9mg
5 Jan 17
Business combination disclosure
12:00am
8-K
zvhtyl48m8unxmdewvr
17 Nov 16
Cost Associated with Exit or Disposal Activities
12:00am
8-K
hris 5itis
10 Nov 16
OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Third Quarter 2016
12:00am
8-K
7rt2r4e3fehvf57x1r
28 Oct 16
Cost Associated with Exit or Disposal Activities
12:00am
8-K
h55 x2t7708jqmtuv
25 Oct 16
OncoGenex Announces Positive Survival Results from Apatorsen Phase 2
12:00am
8-K
l3sne5wvd 13zr
13 Oct 16
OncoGenex Announces Results from the Phase 3 ENSPIRIT Trial of Custirsen in Non-Small Cell Lung Cancer
12:00am
8-K
vsrnhd5nlpy013ha kh
22 Aug 16
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am